U.S. funding pause

Cipla Surpasses Q3 Profit Expectations with Robust Domestic Demand Overcoming Weak US Sales

By Rishika Sadam and Kashish Tandon Cipla, one of India’s top pharmaceutical companies, announced impressive third-quarter profits. The company, which ... Read more